BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12426765)

  • 41. Pathogenesis and management of adult-onset Still's disease.
    Efthimiou P; Georgy S
    Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Adult-onset Still's disease].
    Dalzotto R; Zenklusen C; Kaeser P
    Rev Med Suisse Romande; 1996 Jun; 116(6):459-62. PubMed ID: 8711297
    [No Abstract]   [Full Text] [Related]  

  • 43. Ferritin levels and response to treatment in patients with Adult Still's disease.
    Akritidis N; Giannakakis I; Giouglis T
    J Rheumatol; 1996 Jan; 23(1):201-2. PubMed ID: 8838544
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical thinking and decision making in practice. A young woman with fever, arthralgia and exanthema].
    van Meerten E; Berghout A; Hendriks WD; Swaak AJ
    Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1121-5. PubMed ID: 12092302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low dose methotrexate treatment in adult Still's disease.
    Aydintug AO; D'Cruz D; Cervera R; Khamashta MA; Hughes GR
    J Rheumatol; 1992 Mar; 19(3):431-5. PubMed ID: 1578459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
    Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
    J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
    [No Abstract]   [Full Text] [Related]  

  • 47. [Still's disease in adulthood--case report of a female patient and review of the literature].
    Morović-Vergles J; Galesić K; Seferović M; Skobić N
    Reumatizam; 2002; 49(1):29-32. PubMed ID: 12476751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Refractory adult onset Still's disease successfully treated with anakinra.
    Vasques Godinho FM; Parreira Santos MJ; Canas da Silva J
    Ann Rheum Dis; 2005 Apr; 64(4):647-8. PubMed ID: 15374853
    [No Abstract]   [Full Text] [Related]  

  • 49. [Adult-onset Still's disease. Report of 5 cases].
    Ghiringhelli P; Limbiati S; Maccagni G; Chelazzi G
    Minerva Med; 1999 Apr; 90(4):133-42. PubMed ID: 10518958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Autoimmune hemolytic anemia associated with adult-onset Still's disease].
    Narigasawa Y; Ono Y; Kuriya S
    Rinsho Ketsueki; 2000 Sep; 41(9):729-32. PubMed ID: 11070934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease.
    Komiya A; Matsui T; Nogi S; Iwata K; Futami H; Takaoka H; Arinuma Y; Hashimoto A; Shimada K; Ikenaka T; Nakayama H; Furukawa H; Tohma S
    Scand J Rheumatol; 2012 Mar; 41(2):156-8. PubMed ID: 22420333
    [No Abstract]   [Full Text] [Related]  

  • 52. The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still's disease.
    Lee SW; Park YB; Song JS; Lee SK
    J Rheumatol; 2009 Jan; 36(1):156-62. PubMed ID: 19040301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Adult-onset Still's disease--the effect of methylprednisolone pulse therapy].
    Skoupý J; Alusík S
    Vnitr Lek; 1992 Dec; 38(12):1221-4. PubMed ID: 1296353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
    Naumann L; Feist E; Natusch A; Langen S; Krause A; Buttgereit F; Burmester GR
    Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
    [No Abstract]   [Full Text] [Related]  

  • 55. Potential role of macrophage migration inhibitory factor in adult-onset Still's disease.
    Becker H; Gaubitz M; Domschke W; Willeke P
    Scand J Rheumatol; 2009; 38(1):69-71. PubMed ID: 18686192
    [No Abstract]   [Full Text] [Related]  

  • 56. A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels.
    Ohe M; Bohgaki T
    Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):213-6. PubMed ID: 26535602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes.
    Youssef J; Lazaro E; Blanco P; Viallard JF
    J Rheumatol; 2008 Dec; 35(12):2453-6. PubMed ID: 19143047
    [No Abstract]   [Full Text] [Related]  

  • 58. Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's disease.
    Quartuccio L; De Vita S
    J Rheumatol; 2007 Apr; 34(4):892-3. PubMed ID: 17407250
    [No Abstract]   [Full Text] [Related]  

  • 59. Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
    Vordenbäumen S; Ostendorf B; Sander O; Richter J; Schneider M
    Ann Rheum Dis; 2009 Mar; 68(3):450-1. PubMed ID: 19213754
    [No Abstract]   [Full Text] [Related]  

  • 60. Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile.
    Saiki O; Uda H; Nishimoto N; Miwa T; Mima T; Ogawara T; Azuma N; Katada Y; Sawaki J; Tsutsui H; Matsui K; Maeda A; Nakanishi K
    Clin Immunol; 2004 Jul; 112(1):120-5. PubMed ID: 15207789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.